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Three main sets of costs were included: costs of the preventative strategies under examination; long-term costs associated with routine care (nursing, personal care, food, basic accommodation, and other costs); and costs of managing pressure ulcers, whose severity determined the cost per patient. Most costs were derived from official Ontario sources, including the Ontario Ministry of Health and Long-term Care, the Practice Survey, and the Canadian Institute for Health Information -Discharge Abstract Database. Resource use was taken from the RAI-MDS database and other published sources. Prices of devices and supplies were from manufacturers. Costs were in Canadian dollars (CAD). The price year was 2009. A 3% annual discount rate was applied.
Analysis of uncertainty:
Alternative strategies were analysed by varying the following inputs: excess mortality risk estimate, long-term care perspective, and supply costs only for oral nutritional supplements, skin emollients, and foam cleansing. A probabilistic sensitivity analysis was carried out using conventional probability distributions for model inputs.
Results
For the pressure-redistribution mattress strategy, the incremental cost was -CAD 115 and quality-adjusted life-days 0.31 were compared with standard care.
For the nutritional supplements strategy, the incremental cost was CAD 731 and quality-adjusted life-days were 0.03 compared with standard care.
For the skin emollients strategy, the incremental cost was CAD 24 and quality-adjusted life-days were 0.11 compared with standard care.
For the foam cleansing strategy, the incremental cost was -CAD 179 and quality-adjusted life-days were 0.20 compared with standard care.
The incremental analysis showed that the pressure-redistribution mattress and the foam cleansing strategies were dominant as they were more effective and less expensive than conventional care. The incremental cost per QALY gained over standard care was approximately CAD 7.8 million with the nutritional supplements strategy and CAD 78,286 with the strategy skin emollients strategy.
The sensitivity analysis showed that excluding staff time cost improved the cost-effectiveness of the nutritional supplement strategy, turned the skin emollients strategy into a cost-saving option, and decreased the mean cost saving of the foam cleansing strategy.
At a cost-effectiveness threshold of CAD 50,000 (CAD 100,000) per QALY, the probability of being cost-effective was 94% (96%) for the foam cleansing strategy, 82% (87%) for the pressure-redistribution mattress strategy, 43% (53%) for the skin emollients strategy, and 1% (8%) for the nutritional supplements strategy.
